Exogenous and endogenous markers of tumour oxygenation status - Definitive markers of tumour hypoxia?

被引:0
|
作者
Williams, KJ
Parker, CA
Stratford, IJ
机构
来源
基金
英国医学研究理事会;
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hypoxia is a physiological abnormality that has been detected in all solid tumours analysed to date. Studies using polarographic needle electrodes have shown an unequivocal link between the extent of tumour hypoxia and poor treatment outcome. The practical limitations of polarographic needle electrodes have warranted investigation into alternative strategies enabling routine assessment of tumour hypoxia in the clinical setting. This review focuses on the clinical evaluation of exogenous and endogenous markers of tumour hypoxia that may fulfil this role.
引用
收藏
页码:285 / 294
页数:10
相关论文
共 50 条
  • [31] Tumour markers in chronic kidney disease
    Mercadal, Lucile
    NEPHROLOGIE & THERAPEUTIQUE, 2015, 11 (02): : 122 - 124
  • [32] Tumour markers of prognosis in colorectal cancer
    H L McLeod
    G I Murray
    British Journal of Cancer, 1999, 79 : 191 - 203
  • [33] Serum tumour markers in asymptomatic patients
    Torne Cachot, Joaquim
    Baucells Azcona, Jose Manuel
    Blanch Falp, Jesus
    Blancas Altabella, David
    MEDICINA CLINICA, 2015, 145 (07): : 319 - 320
  • [34] Serum tumour markers in gynaecological cancers
    Aggarwal, Pakhee
    Kehoe, Sean
    MATURITAS, 2010, 67 (01) : 46 - 53
  • [35] Tumour markers: their use and misuse by clinicians
    McGinley, PJ
    Kilpatrick, ES
    ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 : 643 - 647
  • [36] Circulating tumour markers in breast cancer
    Ettore Seregni
    Antonio Coli
    Nicola Mazzucca
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : S15 - S22
  • [37] Circulating tumour markers in breast cancer
    Seregni, E
    Coli, A
    Mazzucca, N
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (Suppl 1) : S15 - S22
  • [38] Relapse chemotherapy and the role of tumour markers
    Rustin, G
    KEY ADVANCES IN THE CLINICAL MANAGEMENT OF OVARIAN CANCER, 2003, : 39 - 42
  • [39] European Group on Tumour Markers (EGTM)
    不详
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2785 - 2787
  • [40] TUMOUR MARKERS IN ORAL AND OROPHARYNGEAL CANCER
    Friedrich, R. E.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6812 - 6813